Imaging-based evaluation of cervical muscle mass and 6-month survival in males with hypopharyngeal carcinoma
DOI:
https://doi.org/10.2340/1651-226X.2024.40481Keywords:
hypopharyngeal cancer, body composition analysis, cachexia, skeletal muscle mass, muscle indexAbstract
Background: A significant proportion of newly diagnosed patients with hypopharyngeal carcinoma (HC) are at risk of early death and may not benefit from cancer treatments. Our objective was to assess whether an image-based evaluation of muscle mass could identify patients at risk of impaired survival.
Materials and methods: This retrospective study consisted of male patients diagnosed with HC treated at Helsinki University Hospital between 2005 and 2014 (N = 66). Cross-sectional areas of skeletal muscles at the level of the third cervical vertebra (C3) and at the level of the thoracic aortic apex were analyzed using magnetic resonance images and/or computed tomography images. Survival-based cutoff values for low muscle index values were determined using the receiver operating characteristics curves. Kaplan-Meier analyses and Cox proportional hazard models were used to evaluate the associations between the muscle indexes and survival rates.
Results: Several muscle indexes were associated with 6-month and 5-year survival. The 6-month survival rate of males with a low sternocleidomastoid muscle index (cutoff 1.73 cm2/m2) was 66%, as opposed to the 97% survival rate for those with an above-the-cutoff muscle index (hazard ratio 13.0 [95% CI 1.5, 116.6]). In a multivariate Cox model adjusted for age, sex, tumor stage, and grade, lower sternocleidomastoid muscle index was significantly associated with decreased 6-month survival.
Interpretation: C3-level muscle indexes, particularly the sternocleidomastoid muscle index, are a promising marker in the identification of patients at risk of early mortality and could add confidence in decision-making when choosing between active and palliative care.
Downloads
References
Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):60–72.
https://doi.org/10.1056/NEJMra1715715 DOI: https://doi.org/10.1056/NEJMra1715715
Keski-Säntti H, Mäkitie AA, Saarilahti K. Intensity-modulated radiotherapy in definitive oncological treatment of hypopharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2015;272(9):2489–95.
https://doi.org/10.1007/s00405-014-3221-1 DOI: https://doi.org/10.1007/s00405-014-3221-1
Koskinen AI, Hemminki O, Försti A, Hemminki K. Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century. BMC Cancer. 2022;22(1):227.
https://doi.org/10.1186/s12885-022-09337-2 DOI: https://doi.org/10.1186/s12885-022-09337-2
Kılıç S, Kılıç SS, Hsueh WD, Eloy JA, Baredes S, Woo Park RC, et al. Radiotherapy modality as a predictor of survival in hypopharyngeal cancer. Head Neck. 2018;40(11):2441–8.
https://doi.org/10.1002/hed.25360 DOI: https://doi.org/10.1002/hed.25360
Keski-Säntti H, Luukkaa M, Carpén T, Jouppila-Mättö A, Lehtiö K, Mäenpää H, et al. Hypopharyngeal carcinoma in Finland from 2005 to 2014: outcome remains poor after major changes in treatment. Eur Arch Otorhinolaryngol. 2023;280(3):1361–7.
https://doi.org/10.1007/s00405-022-07648-5 DOI: https://doi.org/10.1007/s00405-022-07648-5
da Fonseca GWP, Farkas J, Dora E, von Haehling S, Lainscak M. Cancer cachexia and related metabolic dysfunction. Int J Mol Sci. 2020;21(7):2321.
https://doi.org/10.3390/ijms21072321 DOI: https://doi.org/10.3390/ijms21072321
Mäkitie AA, Alabi RO, Orell H, Youssef O, Almangush A, Homma A, et al. Managing cachexia in head and neck cancer: a systematic scoping review. Adv Ther. 2022;39(4):1502–23.
https://doi.org/10.1007/s12325-022-02074-9 DOI: https://doi.org/10.1007/s12325-022-02074-9
Jager-Wittenaar H, Dijkstra PU, Dijkstra G, Bijzet J, Langendijk JA, van der Laan BFAM, et al. High prevalence of cachexia in newly diagnosed head and neck cancer patients: an exploratory study. Nutrition. 2017;35:114–18.
https://doi.org/10.1016/j.nut.2016.11.008 DOI: https://doi.org/10.1016/j.nut.2016.11.008
Pressoir M, Desné S, Berchery D, Rossignol G, Poiree B, Meslier M, et al. Prevalence, risk factors and clinical implications of malnutrition in French comprehensive cancer centres. Br J Cancer. 2010;102(6):966–71.
https://doi.org/10.1038/sj.bjc.6605578 DOI: https://doi.org/10.1038/sj.bjc.6605578
Orell-Kotikangas H, Österlund P, Mäkitie O, Saarilahti K, Ravasco P, Schwab U, et al. Cachexia at diagnosis is associated with poor survival in head and neck cancer patients. Acta Otolaryngol. 2017;137(7):778–85.
https://doi.org/10.1080/00016489.2016.1277263 DOI: https://doi.org/10.1080/00016489.2016.1277263
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39(4):412–23.
https://doi.org/10.1093/ageing/afq034 DOI: https://doi.org/10.1093/ageing/afq034
Prado CMM, Lieff JR, Mccargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–35.
https://doi.org/10.1016/S1470-2045(08)70153-0 DOI: https://doi.org/10.1016/S1470-2045(08)70153-0
Grossberg AJ, Chamchod S, Fuller CD, Mohamed ASR, Heukelom J, Eichelberger H, et al. Association of body composition with survival and locoregional control of radiotherapy-treated head and neck squamous cell carcinoma. JAMA Oncol. 2016;2(6):782–9.
https://doi.org/10.1001/jamaoncol.2015.6339 DOI: https://doi.org/10.1001/jamaoncol.2015.6339
Tolonen A, Pakarinen T, Sassi A, Kyttä J, Cancino W, Rinta-Kiikka I, et al. Methodology, clinical applications, and future directions of body composition analysis using computed tomography (CT) images: a review. Eur J Radiol. 2021;145:109943.
https://doi.org/10.1016/j.ejrad.2021.109943 DOI: https://doi.org/10.1016/j.ejrad.2021.109943
Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol. 2004;97(6):2333–8.
https://doi.org/10.1152/japplphysiol.00744.2004 DOI: https://doi.org/10.1152/japplphysiol.00744.2004
de Bree R, Meerkerk CDA, Halmos GB, Mäkitie AA, Homma A, Rodrigo JP, et al. Measurement of sarcopenia in head and neck cancer patients and its association with frailty. Front Oncol. 2022;12:884988.
https://doi.org/10.3389/fonc.2022.884988 DOI: https://doi.org/10.3389/fonc.2022.884988
Zwart AT, Becker JN, Lamers MJ, Dierckx RAJO, de Bock GH, Halmos GB, et al. Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed. Eur Radiol. 2021;31(6):4053–62.
https://doi.org/10.1007/s00330-020-07440-1 DOI: https://doi.org/10.1007/s00330-020-07440-1
Choi Y, Ahn KJ, Jang J, Shin NY, Jung SL, Kim B-S, et al. Prognostic value of computed tomography-based volumetric body composition analysis in patients with head and neck cancer: feasibility study. Head Neck. 2020;42(9):2614–25.
https://doi.org/10.1002/hed.26310 DOI: https://doi.org/10.1002/hed.26310
Talani C, Mäkitie A, Beran M, Holmberg E, Laurell G, Farnebo L. Early mortality after diagnosis of cancer of the head and neck – a population-based nationwide study. PLoS One. 2019;14(10):e0223154.
https://doi.org/10.1371/journal.pone.0223154 DOI: https://doi.org/10.1371/journal.pone.0223154
Farnebo L, Malila N, Mäkitie A, Laurell G. Early death among head and neck cancer patients. Curr Opin Otolaryngol Head Neck Surg. 2016;24(2):115–20.
https://doi.org/10.1097/MOO.0000000000000236 DOI: https://doi.org/10.1097/MOO.0000000000000236
Peng YC, Wu CH, Tien YW, Lu TP, Wang YH, Chen BB. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy. Eur Radiol. 2021;31(4):2472–81.
https://doi.org/10.1007/s00330-020-07294-7 DOI: https://doi.org/10.1007/s00330-020-07294-7
Swartz JE, Pothen AJ, Wegner I, Smid EJ, Swart KMA, de Bree R, et al. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients. Oral Oncol. 2016;62:28–33.
https://doi.org/10.1016/j.oraloncology.2016.09.006 DOI: https://doi.org/10.1016/j.oraloncology.2016.09.006
Diaz AA, Martinez CH, Harmouche R, Young TP, McDonald ML, Ross JC, et al. Pectoralis muscle area and mortality in smokers without airflow obstruction. Respir Res. 2018;19(1):62.
https://doi.org/10.1186/s12931-018-0771-6 DOI: https://doi.org/10.1186/s12931-018-0771-6
Pishgar F, Shabani M, Silva TQAC, Bluemke DA, Budoff M, Barr RG, et al. Quantitative analysis of adipose depots by using chest CT and associations with all-cause mortality in chronic obstructive pulmonary disease: longitudinal analysis from MESArthritis ancillary study. Radiology. 2021;299(3):703–11.
https://doi.org/10.1148/radiol.2021203959 DOI: https://doi.org/10.1148/radiol.2021203959
Tolonen A, Kerminen H, Lehtomäki K, Huhtala H, Bärlund M, Österlund P, et al. Association between computed tomography-determined loss of muscle mass and impaired three-month survival in frail older adults with cancer. Cancers (Basel). 2023;15(13):3398.
https://doi.org/10.3390/cancers15133398 DOI: https://doi.org/10.3390/cancers15133398
Findlay M, White K, Stapleton N, Bauer J. Is sarcopenia a predictor of prognosis for patients undergoing radiotherapy for head and neck cancer? A meta-analysis. Clin Nutr. 2021;40(4):1711–18.
https://doi.org/10.1016/j.clnu.2020.09.017 DOI: https://doi.org/10.1016/j.clnu.2020.09.017
de Bree R, van Beers MA, Schaeffers AWMA. Sarcopenia and its impact in head and neck cancer treatment. Curr Opin Otolaryngol Head Neck Surg. 2022;30(2):87–93.
https://doi.org/10.1097/MOO.0000000000000792 DOI: https://doi.org/10.1097/MOO.0000000000000792
Findlay M, White K, Brown C, Bauer JD. Nutritional status and skeletal muscle status in patients with head and neck cancer: impact on outcomes. J Cachexia Sarcopenia Muscle. 2021;12(6):2187–98.
https://doi.org/10.1002/jcsm.12829 DOI: https://doi.org/10.1002/jcsm.12829
Martin L, Birdsell L, MacDonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31(12):1539–47.
https://doi.org/10.1200/JCO.2012.45.2722 DOI: https://doi.org/10.1200/JCO.2012.45.2722
Yoon JK, Jang JY, An YS, Lee SJ. Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer. PLoS One. 2021;16(7):e0254844.
https://doi.org/10.1371/journal.pone.0254844 DOI: https://doi.org/10.1371/journal.pone.0254844
Vangelov B, Bauer J, Moses D, Smee R. The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography‐defined sarcopenia assessment in patients with head and neck cancer. Head Neck. 2022;44(5):1047–56.
https://doi.org/10.1002/hed.27000 DOI: https://doi.org/10.1002/hed.27000
Jung AR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer. Oral Oncol. 2019;95:95–9.
https://doi.org/10.1016/j.oraloncology.2019.06.009 DOI: https://doi.org/10.1016/j.oraloncology.2019.06.009
Chargi N, Bril SI, Smid EJ, de Jong PA, de Bree R. Cut-off values for low skeletal muscle mass at the level of the third cervical vertebra (C3) in patients with head and neck cancer. Quant Imaging Med Surg. 2022;12(6):3024–33.
https://doi.org/10.21037/qims-21-911 DOI: https://doi.org/10.21037/qims-21-911
Sanders KJC, Degens JHRJ, Dingemans AMC, Schols AMWJ. Cross-sectional and longitudinal assessment of muscle from regular chest computed tomography scans: L1 and pectoralis muscle compared to L3 as reference in non-small cell lung cancer. Int J COPD. 2019;14:781–9.
https://doi.org/10.2147/COPD.S194003 DOI: https://doi.org/10.2147/COPD.S194003
Kim EY, Kim YS, Park I, Ahn HK, Cho EK, Jeong YM, et al. Evaluation of sarcopenia in small-cell lung cancer patients by routine chest CT. Support Care Cancer. 2016;24(11):4721–6.
https://doi.org/10.1007/s00520-016-3321-0 DOI: https://doi.org/10.1007/s00520-016-3321-0
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Jouni Laurén, Harri Keski-Säntti, Antti Mäkitie, Otso Arponen
This work is licensed under a Creative Commons Attribution 4.0 International License.
